These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22375716)

  • 1. BRCA1 haploinsufficiency: consequences for breast cancer.
    Salmena L; Narod S
    Womens Health (Lond); 2012 Mar; 8(2):127-9. PubMed ID: 22375716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.
    Konishi H; Mohseni M; Tamaki A; Garay JP; Croessmann S; Karnan S; Ota A; Wong HY; Konishi Y; Karakas B; Tahir K; Abukhdeir AM; Gustin JP; Cidado J; Wang GM; Cosgrove D; Cochran R; Jelovac D; Higgins MJ; Arena S; Hawkins L; Lauring J; Gross AL; Heaphy CM; Hosokawa Y; Gabrielson E; Meeker AK; Visvanathan K; Argani P; Bachman KE; Park BH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17773-8. PubMed ID: 21987798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells.
    Zhang X; Wang Y; Chiang HC; Hsieh YP; Lu C; Park BH; Jatoi I; Jin VX; Hu Y; Li R
    Breast Cancer Res; 2019 Apr; 21(1):51. PubMed ID: 30995943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A paradox and three egnimas about the role of BRCA1 in breast and ovarian cancers].
    Feunteun J
    J Soc Biol; 2004; 198(2):123-6. PubMed ID: 15368961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.
    Cuyàs E; Corominas-Faja B; Martín MM; Martin-Castillo B; Lupu R; Brunet J; Bosch-Barrera J; Menendez JA
    Oncotarget; 2017 May; 8(21):35019-35032. PubMed ID: 28388533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.
    Rennstam K; Ringberg A; Cunliffe HE; Olsson H; Landberg G; Hedenfalk I
    Genes Chromosomes Cancer; 2010 Jan; 49(1):78-90. PubMed ID: 19839046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
    Bay JO; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon YJ
    Hum Mutat; 1999; 14(6):485-92. PubMed ID: 10571946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence.
    Sedic M; Skibinski A; Brown N; Gallardo M; Mulligan P; Martinez P; Keller PJ; Glover E; Richardson AL; Cowan J; Toland AE; Ravichandran K; Riethman H; Naber SP; Näär AM; Blasco MA; Hinds PW; Kuperwasser C
    Nat Commun; 2015 Jun; 6():7505. PubMed ID: 26106036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.
    Cuyàs E; Fernández-Arroyo S; Alarcón T; Lupu R; Joven J; Menendez JA
    Oncotarget; 2016 Aug; 7(33):52974-52992. PubMed ID: 27259235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.
    Bell DW; Erban J; Sgroi DC; Haber DA
    Cancer Res; 2002 May; 62(10):2741-3. PubMed ID: 12019146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.
    Birgisdottir V; Stefansson OA; Bodvarsdottir SK; Hilmarsdottir H; Jonasson JG; Eyfjord JE
    Breast Cancer Res; 2006; 8(4):R38. PubMed ID: 16846527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
    King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
    Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers.
    Vaclová T; Gómez-López G; Setién F; Bueno JM; Macías JA; Barroso A; Urioste M; Esteller M; Benítez J; Osorio A
    Breast Cancer Res Treat; 2015 Jul; 152(2):271-82. PubMed ID: 26071757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
    Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 haploinsufficiency, but not heterozygosity for a BRCA1-truncating mutation, deregulates homologous recombination.
    Cousineau I; Belmaaza A
    Cell Cycle; 2007 Apr; 6(8):962-71. PubMed ID: 17404506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
    Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
    Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome.
    Menendez JA; Folguera-Blasco N; Cuyàs E; Fernández-Arroyo S; Joven J; Alarcón T
    Oncotarget; 2016 Mar; 7(11):11959-71. PubMed ID: 26943589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.